Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis
N Al Wachami, M Guennouni, Y Iderdar, K Boumendil… - BMC Public Health, 2024 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a major public health
problem. The present study aims to provide a global and regional estimate of the prevalence …
problem. The present study aims to provide a global and regional estimate of the prevalence …
Inflammation mediates the association between furan exposure and the prevalence and mortality of chronic obstructive pulmonary disease: National Health and …
D Sun, Y Wang, J Wang, N Dilixiati, Q Ye - BMC Public Health, 2024 - Springer
Background Although extensive research has established associations between chronic
obstructive pulmonary disease (COPD) and environmental pollutants, the connection …
obstructive pulmonary disease (COPD) and environmental pollutants, the connection …
Associations between long-term night shift work and incidence of chronic obstructive pulmonary disease: a prospective cohort study of 277,059 UK Biobank …
J Li, L Yang, Y Yao, P Gu, Y Xie, H Yin, M Xue, Y Jiang… - BMC medicine, 2024 - Springer
Background Little is known about the effects of night shifts and their interactions with genetic
factors on chronic obstructive pulmonary disease (COPD). In this study, we aim to …
factors on chronic obstructive pulmonary disease (COPD). In this study, we aim to …
[HTML][HTML] Los determinantes sociales de la salud y su influencia en la prevalencia y pronóstico de la enfermedad pulmonar obstructiva crónica. Una revisión …
I Asensio Whyte, LA Gimeno-Feliu - Revista Clínica de Medicina de …, 2024 - SciELO Espana
Resumen ASENSIO WHYTE, Isabel y GIMENO-FELIU, Luis Andrés. Los determinantes
sociales de la salud y su influencia en la prevalencia y pronóstico de la enfermedad …
sociales de la salud y su influencia en la prevalencia y pronóstico de la enfermedad …
The patients' perspective on living with COPD and their priorities for future research and care
M Senek, A Badyda, S Barbaglia… - COPD in the 21st …, 2024 - books.google.com
This chapter aims to capture the patient's perspective on living with COPD, and their hopes
for future research and care. The review combines data from the published literature, and …
for future research and care. The review combines data from the published literature, and …
[PDF][PDF] Incremental long-term benefit of drug therapies for chronic obstructive pulmonary disease in quality of life but not mortality: a network meta-analysis
Q Pan, J Sun, S Gao, Z Liu… - Archives of …, 2024 - archivesofmedicalscience.com
Introduction: The latest evidence revealed that dupilumab, an interleukin-4 (IL-4) and
interleukin-13 (IL-13) blocker, significantly reduces the exacerbation risk in patients with …
interleukin-13 (IL-13) blocker, significantly reduces the exacerbation risk in patients with …
Occupational exposure to charcoal smoke and dust, a major risk factor for COPD: a multiregional cross-sectional study in the Democratic Republic of Congo
PVO Lofuta, M Klass, N Pauwen, AM Kipula… - Chest, 2024 - Elsevier
SUMMARY BACKGROUND Occupational exposure to charcoal smoke and dust is a threat
to workers respiratory system. RESEARCH QUESTION What is the prevalence of chronic …
to workers respiratory system. RESEARCH QUESTION What is the prevalence of chronic …
Stress Response in Chronic Obstructive Pulmonary Disease-Effect of Cigarette Smoke Extract and Hypoxia on Structural Lung Cells
M Garcia-Ryde - 2024 - portal.research.lu.se
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death
worldwide according to the world health organization. It is a disease characterized by …
worldwide according to the world health organization. It is a disease characterized by …
STep DOWn InhAlers in the Real WorlD (TOWARD): a feasibility study
J ANNANDALE - 2024 - cronfa.swan.ac.uk
INTRODUCTIONCurrent clinical guidelines recommend the use of inhaler corticosteroids
(ICS) in combination with long-acting bronchodilators in the management of chronic …
(ICS) in combination with long-acting bronchodilators in the management of chronic …
Verlauf der FEV1 bei Patienten mit einer COPD-Exazerbation-eine Analyse der JKU-CC/eingereicht von Wollinger Lukas
L Wollinger - 2024 - epub.jku.at
COPD gehört heute zu den drei häufigsten Todesursachen weltweit. Im Jahr 2012 starben
mehr als 3 Millionen Menschen an COPD, was 6% aller Todesfälle weltweit ausmacht …
mehr als 3 Millionen Menschen an COPD, was 6% aller Todesfälle weltweit ausmacht …